Disclosed CapitolDisclosedCapitol
Home
Plans
Chad AI
API
Sign InGet Pro

Never Miss a Trade

Get weekly trade alerts free.

Explore

  • Politician Trades
  • Politicians
  • Executive Branch
  • Companies
  • All Stocks A–Z
  • Leaderboard
  • Compare Politicians
  • Committee Portfolios
  • Chad AI

Money & Policy

  • Government Contracts
  • Lobbying
  • Legislation
  • Campaign Finance
  • Institutional (13F)
  • Whale Watch (13D)

Markets

  • Markets Overview
  • Top Companies
  • Insider Trends
  • Economic Indicators
  • Live News

Resources

  • API Access
  • Developers
  • Developer Guides
  • Data Export
  • Glossary
  • Methodology
  • Data Sources
  • How It Works

Company

  • About Us
  • Press
  • FAQ
  • Pricing
  • vs. Capitol Trades
  • Contact
  • Watchlist

Legal

  • Editorial Standards
  • Corrections
  • Disclaimers
  • Privacy
  • Terms
© 2026 Disclosed Capitol. All rights reserved.
TermsPrivacyDisclaimer
HomeTrades
Chad
WatchlistAccount
All news
PERFORMANCEoutperformer

Ro Khanna MRNA Trade Returns 490.64 Percent Since January 2026 Filing

Chad
·Wednesday, November 18, 2026

Congressional purchases that produced extraordinary gains after their mandatory public filings demonstrate notable patterns across healthcare, technology and energy sectors. These returns are measured from the DISCLOSURE date forward and the public could have seen each of these positions when they were filed. With four distinct members showing verified results above 180 percent, the data points to specific trades where price appreciation accelerated only after the filings became available on senate.gov and house.gov.

Rep. Ro Khanna, D-CA, disclosed a buy in MRNA on January 6, 2026. The position, valued in the $1,001 to $15,000 range, has returned 490.64 percent since that disclosure date. The California Democrat's healthcare sector trade also posted 462.13 percent alpha over 674 days held. Similarly, Rep. Lisa McClain, R-MI, filed her SNDK purchase on November 21, 2025. That technology buy has delivered a 484.33 percent return since disclosure, including an 892.2 percent one-year gain.

Khanna also disclosed a MU buy on November 6, 2025, which has since returned 457.22 percent. The semiconductor name aligns with his other technology exposure. Rep. Tim Moore, R-NC, disclosed a purchase of TZA, the Direxion Daily Small Cap Bear 3X ETF, on July 9, 2025. Despite its inverse structure the position has gained 324.06 percent since filing. These examples, corroborated in official trade data, show how following the public record from the exact disclosure window would have captured the full performance.

Additional verified buys include McClain's ROIV disclosure on August 13, 2025, now up 242.57 percent in the healthcare sector, and Sen. Markwayne Mullin, R-OK, whose larger $50,001-$100,000 VLO buy disclosed on June 11, 2025 has returned 184.3 percent. Days held across the group range from 383 to 730, underscoring longer-term moves rather than fleeting trades. The timing of these filings relative to subsequent appreciation in both biotech and memory-chip names raises questions about sector conviction, though many variables affect market outcomes.

The outperformers carry conviction from the raw filings themselves, with transaction dates preceding disclosure by weeks in each case. While the data reveals clear winners when viewed from the public release point, it also shows variability, as some positions experienced negative 30- and 90-day returns even as longer-term numbers compounded. This snapshot of congressional activity offers retail investors a transparent lens into disclosed trades without implying any predictive power.

This is data analysis, not financial advice.

Mentioned in this article

MRNASNDKMUTZAROIVVLORo KhannaLisa McClainTim MooreMarkwayne Mullin

This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.